BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1253159)

  • 1. In vitro immune responses to viral and tumor antigens in murine breast cancer.
    Sigel MM; Lopez DM; Ortiz-Muniz G
    Cancer Res; 1976 Feb; 36(2 pt 2):748-52. PubMed ID: 1253159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB; Lane MA
    J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.
    Lopez DM; Charyulu V; Sigel MM
    Cancer Res; 1981 Mar; 41(3):813-8. PubMed ID: 6257384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 9. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1975 Jul; 115(1):190-4. PubMed ID: 50346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibition and lymphocyte stimulation with mammary tumor virus associated antigens in Balb/c mice.
    Lopez DM; Ortiz-Muniz G; Sigel MM
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):225-30. PubMed ID: 175373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural immunity in the oncornavirus-infected mouse.
    Blair PB
    Cancer Res; 1976 Feb; 36(2 pt 2):734-8. PubMed ID: 175933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.
    Bekesi JG; Roboz JP; Holland JF
    Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
    Braun DP; Dray S
    Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of cryostat sections of preneoplastic and neoplastic mouse mammary lesions on in vitro migration of peritoneal exudate cells.
    Wei WZ; Miller FR; Blazar BA; Medina D; Heppner G
    J Immunol; 1979 May; 122(5):2059-67. PubMed ID: 448117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
    Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
    Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration inhibition and blastogenic reactions with viral and tumor antigens in transplantable mammary tumor systems.
    Sigel MM; Lopez DM; Ortiz-Muniz G
    Ann N Y Acad Sci; 1976; 276():358-68. PubMed ID: 194519
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor.
    Miller FR; Heppner GH
    J Natl Cancer Inst; 1979 Dec; 63(6):1457-63. PubMed ID: 229294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.